Chang‐Hsien Lu

1.3k total citations
81 papers, 828 citations indexed

About

Chang‐Hsien Lu is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Chang‐Hsien Lu has authored 81 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 27 papers in Surgery and 21 papers in Otorhinolaryngology. Recurrent topics in Chang‐Hsien Lu's work include Head and Neck Cancer Studies (21 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Frailty in Older Adults (10 papers). Chang‐Hsien Lu is often cited by papers focused on Head and Neck Cancer Studies (21 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Frailty in Older Adults (10 papers). Chang‐Hsien Lu collaborates with scholars based in Taiwan, United States and South Korea. Chang‐Hsien Lu's co-authors include Wen‐Chi Chou, Yu‐Shin Hung, Miao‐Fen Chen, Kun‐Yun Yeh, Chia‐Yen Hung, Wen‐Cheng Chen, Jen‐Shi Chen, Chih‐Cheng Chen, Ping‐Tsung Chen and Pei‐Hung Chang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Chang‐Hsien Lu

73 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang‐Hsien Lu Taiwan 16 389 235 210 163 139 81 828
Seong Yoon Yi South Korea 22 487 1.3× 301 1.3× 466 2.2× 105 0.6× 88 0.6× 70 1.2k
Stephan Gripp Germany 13 264 0.7× 295 1.3× 235 1.1× 126 0.8× 103 0.7× 31 817
Graeme J.K. Guthrie United Kingdom 9 1.2k 3.1× 347 1.5× 310 1.5× 58 0.4× 158 1.1× 29 1.6k
Antonio E. Alfonso United States 17 312 0.8× 647 2.8× 231 1.1× 129 0.8× 65 0.5× 45 1.0k
Randall Hughes United States 15 631 1.6× 261 1.1× 889 4.2× 161 1.0× 80 0.6× 43 1.4k
Sanjay Talole India 20 481 1.2× 421 1.8× 330 1.6× 170 1.0× 233 1.7× 54 1.1k
Min-Hsiung Huang Taiwan 22 420 1.1× 570 2.4× 669 3.2× 47 0.3× 124 0.9× 34 1.3k
Akiyoshi Kinoshita Japan 15 739 1.9× 364 1.5× 245 1.2× 36 0.2× 333 2.4× 43 1.2k
Sandeep Samant United States 26 548 1.4× 884 3.8× 425 2.0× 897 5.5× 101 0.7× 76 1.7k
Perran Fulden Yumuk Türkiye 17 588 1.5× 126 0.5× 386 1.8× 17 0.1× 197 1.4× 101 1.0k

Countries citing papers authored by Chang‐Hsien Lu

Since Specialization
Citations

This map shows the geographic impact of Chang‐Hsien Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Hsien Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Hsien Lu more than expected).

Fields of papers citing papers by Chang‐Hsien Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Hsien Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Hsien Lu. The network helps show where Chang‐Hsien Lu may publish in the future.

Co-authorship network of co-authors of Chang‐Hsien Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Hsien Lu. A scholar is included among the top collaborators of Chang‐Hsien Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Hsien Lu. Chang‐Hsien Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chien-Yu, Chun‐Ta Liao, Hung‐Ming Wang, et al.. (2025). Outcome of T2 Glottic Cancer Treated with Radiotherapy Alone or Concurrent Chemo-Radiotherapy. Cancers. 17(4). 712–712.
2.
Tsai, Yao‐Te, Ming‐Hsien Tsai, Geng‐He Chang, et al.. (2024). Prognostic importance of modified geriatric nutritional risk index in oral cavity squamous cell carcinoma. Scientific Reports. 14(1). 12921–12921. 2 indexed citations
3.
Hung, Chia‐Yen, Mei‐Hui Hsu, Shu‐Hui Lee, et al.. (2024). Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT. Journal of the Formosan Medical Association. 123(9). 1010–1017. 2 indexed citations
5.
6.
Fang, Ku‐Hao, Chang‐Hsien Lu, Cheng‐Ming Hsu, et al.. (2023). Prognostic Utility of Neck Lymph Node-to-Primary Tumor Standardized Uptake Value Ratio in Oral Cavity Cancer. Biomedicines. 11(7). 1954–1954. 2 indexed citations
7.
Huang, Yung‐Hsin, Yu‐Shin Hung, Cheng-Chou Lai, et al.. (2021). Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy. Anticancer Research. 41(10). 5213–5222. 6 indexed citations
8.
Lai, Cheng-Chou, Chia‐Yen Hung, Yu‐Ching Lin, et al.. (2021). A comparison of the MNA-SF, MUST, and NRS-2002 nutritional tools in predicting treatment incompletion of concurrent chemoradiotherapy in patients with head and neck cancer. Supportive Care in Cancer. 29(9). 5455–5462. 19 indexed citations
9.
Huang, Cih‐En, Yuying Wu, Wei‐Ming Chen, et al.. (2021). Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection. Biomedical Journal. 45(5). 788–797. 10 indexed citations
10.
Chou, Wen‐Chi, Pei‐Hung Chang, Ping‐Tsung Chen, et al.. (2020). Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). 602–611. 24 indexed citations
11.
Huang, Cih‐En, Yuying Wu, Chia‐Chen Hsu, et al.. (2020). Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms. Journal of the Formosan Medical Association. 120(2). 863–873. 13 indexed citations
12.
Chen, Min‐Chi, et al.. (2018). The bidirectional association among female hormone‐related cancers: breast, ovary, and uterine corpus. Cancer Medicine. 7(6). 2299–2306. 8 indexed citations
13.
Huang, Pei‐Wei, Wen‐Chi Chou, Wen‐Chi Shen, et al.. (2018). Hand–foot skin reaction predicts treatment outcome of pazopanib in patients with metastatic soft tissue sarcoma: A multicenter study in the Asian population. Asia-Pacific Journal of Clinical Oncology. 14(4). 353–360. 7 indexed citations
14.
Hung, Chia‐Yen, Cheng-Chou Lai, Ping‐Tsung Chen, et al.. (2018). Impact of body mass index on long-term survival outcome in Asian populations with solid cancer who underwent curative-intent surgery: A six-year multicenter observational cohort study. Journal of Cancer. 9(18). 3316–3325. 5 indexed citations
15.
Lu, Chang‐Hsien, Chien-Ting Liu, Chia‐Yen Hung, et al.. (2017). Develop and validation a nomogram to predict the recurrent probability in patients with major salivary gland cancer. Journal of Cancer. 8(12). 2247–2255. 12 indexed citations
17.
Kuan, Feng‐Che, Ching‐Chuan Hsieh, Kam-Fai Lee, et al.. (2012). Pseudomyxoma Peritonei Mimicking Acute Appendicitis and Peritonitis. 28(4). 170–176.
18.
Lu, Chang‐Hsien, et al.. (2008). Alpha-fetoprotein-producing transitional cell carcinoma of the urinary bladder: a case report. International Urology and Nephrology. 41(3). 567–570. 6 indexed citations
19.
Chen, Wen‐Cheng, Wen–Hung Wang, Chang‐Hsien Lu, et al.. (2008). Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncology. 45(6). 505–510. 45 indexed citations
20.
Chou, Wen‐Chi, Chang‐Hsien Lu, Gigin Lin, et al.. (2007). Transcutaneous arterial embolization to control massive tumor bleeding in head and neck cancer: 63 patients’ experiences from a single medical center. Supportive Care in Cancer. 15(10). 1185–1190. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026